tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MiMedx sees FY25 revenue up low double-digits percent

Sees FY25 adjusted EBITDA margin above 20%. The company said, “Longer-term, the Company continues to expect to achieve annual net sales growth in the low double-digits as a percentage with an adjusted EBITDA margin above 20%.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1